Sign In   |   Register
Menu

During the month of September the Society elections are ongoing. For information and to vote go to "About EAS"/"Governance, elections & committees" in the top menu.

2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

The 2019 Joint European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS) Dyslipidaemia Guidelines were released on 31 August during the ESC Congress, Paris, France. These novel ESC/EAS Guidelines on lipids provide important new advice on patient management, which should enable more clinicians to efficiently and safely reduce CV risk through lipid modification. What were the key changes to those published in 2016? In the video below, the EAS contributors Professor Alberico L. Catapano, Professor Lale Tokgozoglu, and Professor Olov Wiklund describe key changes and what they will mean for practicing clinicians.

 

Read the guidelines >>
What's new? Read the commentary >>

EAS FH Studies Collaboration reports first patient data at ESC Congress Paris 2019

Familial Hypercholesterolaemia Studies Collaboration, a global registry of over 61,000 people with this common inherited high cholesterol disorder - the only global registry on FH

The first patient data from the European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (FHSC), the only global registry on FH, highlight the need for more intensive therapy to reduce low-density lipoprotein cholesterol (LDL C), ‘bad cholesterol‘, in people with FH. Among 42,000 adults with heterozygous FH, only about half received a statin at the time of entry to the registry. Of people on a statin, over 85 per cent had LDL-C levels at entry that were above European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) recommended targets for people with FH. The findings were reported during the ESC Congress, 31 August-4 September, Paris, France.

Read the full report >>

Author Antonio Vallejo-Vaz, of Imperial College, London, talks to medical journalist Dr Jane Stock about the FHSC and these findings.


Member sign in



Access the Society journals



Log in to access Atherosclerosis >>

Calendar more

01/07/2019 » 31/10/2019
Submit your paper for the "Best Paper Award 2020"

02/09/2019 » 30/09/2019
EAS Society elections || Voting open for individual members

23/09/2019 » 29/09/2019
FH Week 2019

EAS Academy
EAS Journal
Become an EAS Member
Guidelines
Membership Software Powered by YourMembership  ::  Legal
This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.